Editorial: Hereditary Spastic Paraplegias: At the Crossroads of Molecular Pathways and Clinical Options
Front. Neurosci.. 2021-06-22; 15:
DOI: 10.3389/FNINS.2021.708642
Lire sur PubMed
Martinuzzi A(1), Blackstone C(2), O’Kane CJ(3), Stevanin G(4).
Author information:
(1)Department of Conegliano, Istituto di Ricovero e Cura a Carattere Scientifico
« E. Medea » Scientific Institute, Pieve di Soligo, Italy.
(2)Department of Neurology, Massachusetts General Hospital, Boston, MA, United
States.
(3)Department of Genetics, University of Cambridge, Cambridge, United Kingdom.
(4)Paris Sciences Lettres Research University, EPHE, Institut du Cerveau – Paris
Brain Institute, Sorbonne Université, INSERM, CNRS, APHP, Paris, France.
DOI: 10.3389/fnins.2021.708642
PMCID: PMC8258316
PMID: 34239414
Conflict of interest statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.